Study design:

• ForsLean® was tested in an open-field study with a population of six overweight women (BMI greater than 25).
  
  
• The tested formula was in the form of two-piece, hard shell capsules; each capsule contained 250 mg of the extract.
  
  
• The overweight, but otherwise healthy women, received the forskohlin formula twice daily for eight weeks.
  
  
• Participants were instructed to take one capsule in the morning and one in the evening, half an hour before a meal.
  
  
• Each participant was asked to maintain her previous daily physical exercise and eating habits.
  
  
• In addition, physical activity was monitored based on a questionnaire before and during the trial.
  
  

Results:
During the eight week trial, the mean values for body weight and fat content significantly decreased, whereas lean body mass was significantly increased compared to baseline values (Figure 1).

The regimen did not adversely affect the systolic/diastolic blood pressure nor the pulse rate. Indeed, a trend towards lower systolic/diastolic pressure was observed during the course of treatment (Figure 2).